PRMT5-IN-19
PRMT5-IN-19 (Compound 41) is an selective orally active non-nucleoside PRMT5 inhibitor with IC50 values of 23.9 nM (radioactive biochemical assay) and 47 nM (AlphaLISA assay). PRMT5-IN-19 can occupy the SAM-binding pocket in PRMT5 and block methyltransferase activity, which displays good selectivity over other PRMTs and PKMTs. PRMT5-IN-19 inhibits cell proliferation by inducing cell apoptosis, and can be used for cancer-related research.
For research use only. We do not sell to patients.
- CAS No.: 2783961-86-2
- Formula: C25H24N4O
- Molecular Weight:396.48
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
-
Biological Activity
-
Chemical Information
- Purity & Documentation
- References
-
Help & FAQs
All Histone Methyltransferase Isoforms
More
Biological Activity
|
PRMT5 23.9 nM (IC50) |
PRMT1 3.252 μM (IC50) |
PRMT4 >20 μM (IC50) |
PRMT5-IN-19 (Compound 41, 5 days) has strong anti-proliferative effects against the A375 cell with an IC50 value of 1.36 μM[1].
PRMT5-IN-19 shows higher selectivity for PRMT5 (IC50 value of 23.9 nM) than other histone methyltransferases (PRMT1 and PRMT4), and PKMTS (EZH2, NSD2, MLL1, and MLL4) [1].
PRMT5-IN-19 binds with the SAM-binding pocket in PRMT5[1].
PRMT5-IN-19 (4-5 days) Inhibits proliferation of multiple cancer cell lines (A-375, CHL-1, SNU-423, SNU-449, MDA-MB-231, MDA-MA-453, MV-4-11, MOLM13) with IC50 value ranging from 1.08 to 3.45 μM[1].
PRMT5-IN-19 inhibits arginine symmetrical dimethylation in A375 cells [1].
PRMT5-IN-19 (0-4 μM, 48 h) suppresses A375 cell proliferation by inducing apoptosis in a concentration-dependent manner[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:A-375, CHL-1, SNU-423, SNU-449, MDA-MB-231, MDA-MA-453, MV-4-11, MOLM13
-
Concentration:0-10 μM
-
Incubation Time:5 days
-
Result:Inhibited proliferation of multiple cancer cell lines with IC50 value ranging from 1.08 to 3.45 μM.
-
Cell Line:A-375 cells
-
Concentration:0.5, 1, 2, 4,8 μM
-
Incubation Time:48 h.
-
Result:Inhibited arginine symmetrical dimethylation in a dose-dependent manner.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:A375 cell-derived nude mouse xenograft model[1].
-
Dosage:75 mg/kg/d
-
Administration:P.o., 19 days
-
Result:Had no effect on the body weight, displayed antitumor efficacy with a tumor growth inhibition (TGI) rate of 73% by inhibiting the methyltransferase activity of PRMT5.
-
Animal Model:Rats and mice[1].
-
Dosage:10 mg/kg for p.o., 3 mg/kg for i.v
-
Administration:P.o., i.v. (Pharmacokinetic Analysis)
-
Result:Pharmacokinetic parameters for PRMT5-IN-19 in SD Rats and Micea,c [1].
species PRMT5-IN-19 T1/2 (h) Cmax (ng/mL) CL (mL/min/kg) F (%) rat iv (3 mg/kg)/td> 2.58 310 po (10 mg/kg)/td> 7.51 8.22 7.25 po (10 mg/kg)/td> 2.95 27.7 23.7 mouse iv (3 mg/kg)/td> 4.71 153 po (10 mg/kg)/td> 128 --> 
Chemical Information
-
CAS No. 2783961-86-2
-
Molecular Weight 396.48
-
Formula C25H24N4O
-
SMILES
C[C@H](OC1=CC=C(C2=CC3=C(N=CN=C3N2)C4=CCNCC4)C=C1)C5=CC=CC=C5
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Purity & Documentation
Select Batch:Purity: 99.98%Assay: 99.98%ee.: 99.98%
References
Calculators
Molarity CalculatorMass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)= × ×Dilution CalculatorConcentration (start) × Volume (start) = Concentration (final) × Volume (final)
×=×
PRMT5-IN-19 Related Classifications
Cat. No.: HY-149005
KeywordsAssay Types -
Powered by Bioz